Dr Taryn Kline Fernandes, MD in Union Grove, WI - Medicare General Practice

Dr Taryn Kline Fernandes, MD is a medicare enrolled "General Practice" physician in Union Grove, Wisconsin. Her current practice location is 163 11th Ave, Union Grove, Wisconsin. You can reach out to her office (for appointments etc.) via phone at (530) 356-6739.

Dr Taryn Kline Fernandes is licensed to practice in Florida (license number 153791) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1508396292.

Contact Information

	Dr Taryn Kline Fernandes, MD
	163 11th Ave, Union Grove, WI 53182-1282
	(530) 356-6739
	Not Available

Physician's Profile

Full Name	Dr Taryn Kline Fernandes
Gender	Female
Speciality	General Practice
Location	163 11th Ave, Union Grove, Wisconsin
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1508396292
Provider Enumeration Date: 06/14/2017
Last Update Date: 12/20/2021

Medicare PECOS Information:

PECOS PAC ID: 6406248947
Enrollment ID: I20220113001380

Medical Identifiers

Medical identifiers for Dr Taryn Kline Fernandes such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1508396292	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	153791 (Florida)	Primary
207R00000X	Internal Medicine	125.071000 (Illinois)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Taryn Kline Fernandes is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Taryn Kline Fernandes, MD 163 11th Ave, Union Grove, WI 53182-1282 Ph: (530) 356-6739	Dr Taryn Kline Fernandes, MD 163 11th Ave, Union Grove, WI 53182-1282 Ph: (530) 356-6739

News Archive

Nanotubes detect tumors and deliver high-potency punch

Researchers at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have found a new way to target cancer cells while leaving healthy cells untouched.

Cephalon to acquire Alba Therapeutics

Cephalon, Inc. and Alba Therapeutics Corporation, a privately held biopharmaceutical company, today announced that the companies have signed an agreement providing Cephalon with an option to purchase all of Alba's assets relating to larazotide acetate, a tight junction modulator, progressing toward a Phase IIb clinical trial for the treatment of celiac disease.

WSJ: Insurers' profits on the rise

Health insurers' fourth-quarter reports will provide an early glimpse into how much wind the health overhaul could take out of plans' profits—and, so far, Wall Street estimates don't look all that bad for the industry (Johnson, 1/20).

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.

Dr Taryn Kline Fernandes, MD - Medicare General Practice in Union Grove, WI